Gambogenic acid inhibits fibroblast growth factor receptor signaling pathway in erlotinib-resistant non-small-cell lung cancer and suppresses patient-derived xenograft growth

FGFRgene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib

(2016) Masaaki Hibi et al.   CANCER SCIENCE

EGFR Testing in Advanced Non–Small-Cell Lung Cancer, A Mini-Review

(2016) Yuri Sheikine et al.   Clinical Lung Cancer

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin

(2015) Ye He et al.   BMC Complementary and Alternative Medicine

FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitor

(2015) Koichi Azuma et al.   Oncotarget

Clinical Pharmacology of EGFR/Met Inhibitors in Non-Small Cell Lung Cancer

(2014) Shigehiro Yagishita et al.   CURRENT DRUG TARGETS

Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling

(2013) L-H Wang et al.   BRITISH JOURNAL OF CANCER

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

New targets for the antitumor activity of gambogic acid in hematologic malignancies

(2012) Li-jing Yang et al.   ACTA PHARMACOLOGICA SINICA

Gambogic Acid Is a Tissue-Specific Proteasome Inhibitor In Vitro and In Vivo

(2012) Xiaofen Li et al.   Cell Reports

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prenylated caged xanthones: Chemistry and biology

(2011) Natthinee Anantachoke et al.   PHARMACEUTICAL BIOLOGY

Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1α in non-small cell lung cancer cells

(2010) L Xu et al.   ONCOGENE

Gambogic acid covalently modifies IκB kinase-β subunit to mediate suppression of lipopolysaccharide-induced activation of NF-κB in macrophages

(2009) Umamaheshwari D. Palempalli et al.   BIOCHEMICAL JOURNAL

Caged Garcinia Xanthones: Development Since 1937

(2009) Q.-B. Han et al.   CURRENT MEDICINAL CHEMISTRY

Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition

(2008) Hendrik Fischer et al.   MOLECULAR CANCER THERAPEUTICS

Proteomic identification of molecular targets of gambogic acid: Role of stathmin in hepatocellular carcinoma

(2008) Xin Wang et al.   PROTEOMICS